AxoGen
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Florida, United States · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
13631 Progress Blvd Ste 400, Alachua, Fl...Phone Number
(386) 462-6800Website
www.axogeninc.comRevenue
$238.1 MillionStock Symbol
AXGNIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
5
5
1
1
1
1
About AxoGen
AxoGen is a medical device manufacturing company founded in 2002 that specializes in developing and producing surgical solutions for peripheral nerve injuries. The company offers a comprehensive portfolio of products including nerve grafts, connectors, and protectors designed to facilitate nerve repair and regeneration. AxoGen's innovative solutions include the Avance Nerve Graft for bridging severed nerves, AxoGuard Nerve Connector for tensionless nerve repair, and AxoGuard Nerve Protector for protecting injured peripheral nerves. Additionally, the company provides diagnostic and measurement tools such as the AcroVal neurosensory testing system and AxoTouch discriminator. AxoGen distributes its products to hospitals, surgery centers, and military medical facilities across North America, Europe, and other international markets, serving the needs of surgeons and patients in peripheral nerve repair procedures.Explore more
AxoGen Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is AxoGen your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check if AxoGen has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once AxoGen has new funding data
Congratulate Masked Content for being promoted to Masked Content at AxoGen
Earning: See what the market has to say on AxoGen recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if AxoGen had a recent Job posting/layoffs
AxoGen, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when AxoGen launches new products
Check out if AxoGen is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined AxoGen as Masked Content
Find more new buyers
Compare Similar Companies to AxoGen
Compare insights from companies similar to AxoGen, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
AxoGen is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
AxoGen is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about AxoGen.
AxoGen financials insights
Gather financial insights about AxoGen, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2006
Series B
$7.8M
2007
Series C
$12.1M
2009
Debt
$2.6M
2011
Debt
$3.7M
Debt
$3M
2013
Stock Offering
$18M
2015
Share Placement
$17.1M
2020
Debt
$35M
AxoGen Tech Stack
A closer look at the technologies used by AxoGen
See more technologies
Most Recent Scoops
Open Position
Person-Based
Corporate Strategy
Person-Based
Events
Person-Based
Events
Open Position
AxoGen News & Media
Axogen CMO sells 4,000 shares in open market | AXGN Insider Trading - Stock Titan
Axogen CMO Jens Kemp sold 4,000 AXGN shares at a weighted $43.44, in multiple trades between $43.44 and $43.45, leaving him with 72,451 shares.Axogen, Inc. to Participate in the 2026 Bank of America Global Healthcare Conference
ALACHUA, Fla. and TAMPA, Fla., April 30, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced that the company will be participating in the upcoming 2026 Bank of America Global Healthcare Conference.AxoGen Q1 Earnings Call Highlights
AxoGen (NASDAQ:AXGN) reported first-quarter 2026 revenue of $61.5 million, up 26.6% year over year, as management pointed to broad-based growth across its target markets and continued adoption of its product algorithm led by Avance Nerve Graft. President and CEO Michael Dale said the company’s perfoAxogen, Inc. Reports First Quarter 2026 Financial Results
Raises Full Year Revenue Guidance to at Least 20% Growth or $270 million Raises Full Year Revenue Guidance to at Least 20% Growth or $270 million
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding AxoGen
Sign Up For FreeTo access detailed company insights
AxoGen is a medical device manufacturing company founded in 2002 that specializes in developing and producing surgical solutions for peripheral nerve injuries. The company offers a comprehensive portfolio of products including nerve grafts, connectors, and protectors designed to facilitate nerve repair and regeneration. AxoGen's innovative solution... Read More
